Matches in Nanopublications for { ?s ?p "[Xeroderma pigmentosum group D (XPD Lys751Gln) polymorphism may be an important marker in the prediction of clinical outcome to chemo-radiotherapy in resected gastric cancer patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 8 of
8
with 100 items per page.
- NP105895.RAzlHjV-MoSBtxX23fU1JRCq5uZ97KYkMdW-HGn_SKrCg130_assertion description "[Xeroderma pigmentosum group D (XPD Lys751Gln) polymorphism may be an important marker in the prediction of clinical outcome to chemo-radiotherapy in resected gastric cancer patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP105895.RAzlHjV-MoSBtxX23fU1JRCq5uZ97KYkMdW-HGn_SKrCg130_provenance.
- NP152886.RAsgMvD5AOXABpdKMi19w-9aWw1yseNRcN9rTxyxjfhE4130_assertion description "[Xeroderma pigmentosum group D (XPD Lys751Gln) polymorphism may be an important marker in the prediction of clinical outcome to chemo-radiotherapy in resected gastric cancer patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP152886.RAsgMvD5AOXABpdKMi19w-9aWw1yseNRcN9rTxyxjfhE4130_provenance.
- NP169113.RAedvEQgUEPSnk5-IMCEVsC06lZJbMerHUdaP7n8APNNQ130_assertion description "[Xeroderma pigmentosum group D (XPD Lys751Gln) polymorphism may be an important marker in the prediction of clinical outcome to chemo-radiotherapy in resected gastric cancer patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP169113.RAedvEQgUEPSnk5-IMCEVsC06lZJbMerHUdaP7n8APNNQ130_provenance.
- assertion description "[Xeroderma pigmentosum group D (XPD Lys751Gln) polymorphism may be an important marker in the prediction of clinical outcome to chemo-radiotherapy in resected gastric cancer patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Xeroderma pigmentosum group D (XPD Lys751Gln) polymorphism may be an important marker in the prediction of clinical outcome to chemo-radiotherapy in resected gastric cancer patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP219949.RAAGuoUwPElpBdwa2kOcly5EjLNIIkvJYhA7wDOLBIXL8130_assertion description "[Xeroderma pigmentosum group D (XPD Lys751Gln) polymorphism may be an important marker in the prediction of clinical outcome to chemo-radiotherapy in resected gastric cancer patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP219949.RAAGuoUwPElpBdwa2kOcly5EjLNIIkvJYhA7wDOLBIXL8130_provenance.
- NP219948.RAuXccjZb33shGeu7V7Sx5o5Wsz-Mc154terv_nDQIgfk130_assertion description "[Xeroderma pigmentosum group D (XPD Lys751Gln) polymorphism may be an important marker in the prediction of clinical outcome to chemo-radiotherapy in resected gastric cancer patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP219948.RAuXccjZb33shGeu7V7Sx5o5Wsz-Mc154terv_nDQIgfk130_provenance.
- NP215998.RAGqKvfFqLe6xlP8aTeX0ivYaFujURRXpJABxnZ7vgkPM130_assertion description "[Xeroderma pigmentosum group D (XPD Lys751Gln) polymorphism may be an important marker in the prediction of clinical outcome to chemo-radiotherapy in resected gastric cancer patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP215998.RAGqKvfFqLe6xlP8aTeX0ivYaFujURRXpJABxnZ7vgkPM130_provenance.